Product Images Atorvastatin Calcium
View Photos of Packaging, Labels & Appearance
- Unit Carton - export 00
- Atorvastatin Calcium Tablets, USP 80 mg Unit Carton Label - export 01
- Atorvastatin Calcium Structural Formula - image 01
- Atorvastatin Calcium Tablets, USP 10 mg Unit Carton Label - image 02
- Atorvastatin Calcium Tablets, USP 10 mg Unit Carton Label - image 03
- Atorvastatin Calcium Tablets, USP 40 mg Unit Carton Label - image 04
- Figure 1: Effect of Atorvastatin Calcium Tablets 10 mg/day on Cumulative Incidence of Non-Fatal Myocardial Infarction or Coronary Heart Disease Death (in ASCOT-LLA) - image 06
- Figure 2: Effect of Atorvastatin Calcium Tablets 10 mg/day on Time to Occurrence of Major Cardiovascular Event (myocardial infarction, acute CHD death, unstable angina, coronary revascularization, or - image 07
- Figure 3: Effect of Atorvastatin Calcium Tablets 80 mg/day vs. 10 mg/day on Time to Occurrence of Major Cardiovascular Events (TNT) - image 08
- Unit Carton - image 09
- Unit Carton - image 10
- Unit Carton - image 11
Product Label Images
The following 12 images provide visual information about the product associated with Atorvastatin Calcium NDC 48433-009 by Safecor Health, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Atorvastatin Calcium Tablets, USP 40 mg Unit Carton Label - image 04
This is a description of Atorvastatin Calcium tablets in a package containing 100 tablets (10x10). The NDC number for the product is 48433-009-20. The instructions on the package likely include dosage guidance and storage instructions.*
Figure 1: Effect of Atorvastatin Calcium Tablets 10 mg/day on Cumulative Incidence of Non-Fatal Myocardial Infarction or Coronary Heart Disease Death (in ASCOT-LLA) - image 06
This text provides information on cumulative incidence (%) and hazard ratio (HR=0.64, 95% CI 0.50-0.83) over a period of 35 years. The data is presented in a graphical format showing the cumulative incidence percentages over time.*
Figure 2: Effect of Atorvastatin Calcium Tablets 10 mg/day on Time to Occurrence of Major Cardiovascular Event (myocardial infarction, acute CHD death, unstable angina, coronary revascularization, or - image 07
This text provides information on the cumulative hazard at 15%, hazard ratio of 0.63 with a confidence interval of 0.48-0.83 and a p-value of 0.001. It also mentions the time to the first primary endpoint through four years of follow-up.*
Figure 3: Effect of Atorvastatin Calcium Tablets 80 mg/day vs. 10 mg/day on Time to Occurrence of Major Cardiovascular Events (TNT) - image 08
This text provides data on the percentage of subjects experiencing an event for two different dosages of Atorvastatin (10 mg and 80 mg) over time, along with hazard ratio (HR) values and p-values. It also presents information on the time to the first major cardiovascular endpoint in years.*
Unit Carton - image 11
This is a description of a packaging label for a product distributed by Safecor Health Company. The packaging is described as not being child-resistant. The container is intended for institutional use only. It emphasizes keeping all drugs out of reach of children and mentions high resistance. Additionally, the packaging lacks a window for lot number and expiration date. Contact information for Safecor Health is provided, including their phone number and website.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.